Bioadaptives (BDPT) Shares Outstanding (Diluted Average) (2019 - 2026)

Bioadaptives has disclosed Shares Outstanding (Diluted Average) across 5 years of filings, most recently posting $12.0 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $12.0 million, up 32.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.0 million (up 32.71% YoY), and the FY2025 annual result was $10.1 million, up 22.61% from the prior year.
• Shares Outstanding (Diluted Average) came in at $12.0 million for Q1 2026 at Bioadaptives, up from $10.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $12.0 million in Q1 2026 to a low of $3.0 million in Q2 2024.
• The 3-year median for Shares Outstanding (Diluted Average) is $9.0 million (2025), against an average of $8.6 million.
• Peak annual rise in Shares Outstanding (Diluted Average) reached 201.36% in 2025, while the deepest fall reached 17.54% in 2025.
• Bioadaptives' Shares Outstanding (Diluted Average) stood at $8.2 million in 2024, then climbed by 22.61% to $10.1 million in 2025, then grew by 19.22% to $12.0 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $12.0 million (Q1 2026), $10.1 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.